急性内科入院患者酒精滥用普遍筛查可行且可识别肝病高风险人群
研究在大型急性医院急性内科单元实时电子筛查所有入院患者,2011年7月至2014年3月共53,165例次入院,48,211例次(90.68%)完成筛查。2.3%被归为酒精危害风险「增加」,4.0%为「高」风险;高风险组既往3年入院次数和急诊就诊次数均更多。结论认为普遍筛查可行,可识别频繁急诊就诊、反复入院和酒精相关肝病风险升高的人群。
要点
- 普遍筛查可行:48,211/53,165例次入院(90.68%)完成筛查。
- 高风险组既往3年平均入院4.74次,高于低风险组3.00次和增加风险组2.92次(p<0.001)。
- 高风险组平均急诊就诊7.68次,高于低风险组2.64次和增加风险组3.81次(p均<0.001)。
核心结论
- 入院酒精滥用普遍筛查可行,可识别频繁急诊就诊、反复入院和酒精相关肝病风险升高的人群。
- 还可识别酒精危害风险增加、表现为多种常见就诊原因的另一组患者,可针对这些患者实施干预以减少酒精相关危害负担。
研究设计与样本
- 研究系统性筛查大型急性医院急性内科单元所有入院患者,采用实时电子数据采集系统,筛查时间为2011年7月至2014年3月。
- 共53,165例次入院,48,211例次(90.68%)完成筛查;风险增加者转介简短干预或酒精专科护理服务进一步评估。
- 记录入院诊断、酒精单位消耗、既往就诊、既往入院、住院天数和死亡率。
主要发现
- 1,122例次(2.3%)被归为酒精危害风险「增加」,1,921例次(4.0%)为「高」风险。
- 高风险组既往3年平均入院4.74次,低风险组3.00次,增加风险组2.92次(p<0.001)。
- 高风险组平均急诊就诊7.68次,低风险组2.64次,增加风险组3.81次(p均<0.001)。
- 高风险组中1,396例次(72.6%)接受酒精专科护理服务评估,1,135例次(81.2%)AUDIT评分超过20分,其中527例次(37.8%)记录为最高值40分。
- 高风险组最常见入院诊断为精神健康障碍、胃肠道出血、中毒和肝病。
临床怎么用
- 作者认为入院酒精滥用普遍筛查可行,可识别频繁急诊就诊、反复入院和酒精相关肝病风险升高的人群。
- 作者认为风险增加组可在多种常见就诊表现中被识别,这些患者可 targeting 干预以减少酒精相关危害负担。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Many people who die from alcohol related liver disease (ARLD) have a history of recurrent admissions to hospital, representing potential missed opportunities for intervention. Universal screening for alcohol misuse has been advocated but it is not known if this is achievable or effective at detecting individuals at high risk of ARLD. METHODS: We systematically screened all admissions to the Acute Medical Unit (AMU) of a large acute hospital using an electronic data capture system in real time. Patients at an increasing risk of alcohol harm were referred for either brief intervention (BI) or further assessment by an Alcohol Specialist Nursing Service (ASNS). Additional data were recorded on admission diagnoses, alcohol unit consumption, previous attendances, previous admissions, length of stay and mortality. RESULTS: Between July 2011 and March 2014, there were 53,165 admissions and 48,211 (90.68%) completed screening. Of these, 1,122 (2.3%) were classified as "increasing", and 1,921 (4.0%) as "high" risk of alcohol harm. High risk patients had more hospital admissions in the three previous years (average 4.74) than the low (3.00) and increasing (2.92) risk groups (p<0.001). The high risk patients also had more frequent emergency department (ED) attendances (7.68) than the lower (2.64) and increasing (3.81) groups (p<0.001 for both). A total of 1,396 (72.6%) of the high risk group were seen by the ASNS and 1,135 (81.2%) had an Alcohol Use Disorders Identification Test (AUDIT) score over 20 with 527 (37.8%) recording the maximum value of 40. Compared to the other groups, high risk patients had a distinct profile of admissions with the most common diagnoses being mental health disorders, gastro-intestinal bleeding, poisoning and liver disease. CONCLUSIONS: Universal screening of admissions for alcohol misuse is feasible and identifies a cohort with frequent ED attendances, recurrent admissions and an elevated risk of ARLD. An additional group of patients at an increasing risk of alcohol harm can be identified in a range of common presentations. These patients can be targeted with interventions to reduce the burden of alcohol related harm. Lay summary: Many people who die from alcohol related liver disease (ARLD) have a recent history of recurrent admissions to hospital. These admissions may represent missed opportunities to intervene earlier and offer effective therapies for alcohol misuse. Unfortunately, we know that patients are often missed because medical staff may not routinely ask about alcohol consumption. In our study of over 50,000 admissions, we have demonstrated the feasibility of offering screening for alcohol misuse to all medical admissions to hospital and delivered this 24hours a day, 7days a week, with automatic referral to treatment services. We have shown that it is possible to identify those people who are at the highest risk of dependency, those who have attended the emergency department the most and those who are at an increased risk of ARLD. We hope this study will lead to improved detection and management of alcohol problems in acute hospitals.
引用
- Westwood G, Meredith P, Atkins S, et al. Universal screening for alcohol misuse in acute medical admissions is feasible and identifies patients at high risk of liver disease. J Hepatol. 2017. PMID: 28756907. doi:10.1016/j.jhep.2017.04.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。